Candel Therapeutics Inc (CADL)

11:20 AM

Small cap wrap: Excellon Resources, Candel Therapeutics, Forte Minerals... - Proactive financial news

11:20 AM

04:37 AM

Candel Therapeutics to present Phase 3 prostate cancer trial data at ASCO 2025 - Proactive financial news

04:37 AM

01:49 AM

Candel Therapeutics, Inc. (CADL) to Present Positive Phase 3 Prostate Cancer Data at ASCO 2025 - Yahoo Finance

01:49 AM

May 22, 2025

Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025 - GlobeNewswire

May 22, 2025

May 22, 2025

Breakthrough Phase 3 Results: First Successful Prostate Cancer Trial in 20 Years Shows 30% Lower Recurrence Risk - Stock Titan

May 22, 2025

May 19, 2025

Best Momentum Stocks to Buy for May 19th - The Globe and Mail

May 19, 2025

May 19, 2025

New Strong Buy Stocks for May 19th - The Globe and Mail

May 19, 2025

May 17, 2025

Wall Street Analysts Predict a 310.96% Upside in Candel Therapeutics (CADL): Here's What You Should Know - MSN

May 17, 2025

May 15, 2025

CADL To Present Prostate Cancer Trial Data, RMD's Q3 Revenue Climbs 8%, AUNA On Watch... - RTTNews

May 15, 2025

May 14, 2025

Promising Pipeline Developments and Strong Data Support Buy Rating for Candel Therapeutics - TipRanks

May 14, 2025

May 14, 2025

Candel Therapeutics Reports Strong Q1 2025 Results - TipRanks

May 14, 2025

May 13, 2025

CADL's Cash Reserves Projected to Last Until Early 2027 | CADL S - GuruFocus

May 13, 2025

May 13, 2025

Candel Therapeutics Stock Jumps On Upbeat Q1 Earnings: Retail Gets More Bullish - NewsBreak: Local News & Alerts

May 13, 2025

May 13, 2025

Candel Therapeutics Stock Jumps On Upbeat Q1 Earnings: Retail Gets More Bullish By Stocktwits - Investing.com India

May 13, 2025

May 13, 2025

Small cap wrap: Candel Therapeutics, Nevis Brands, Fineqia, Voyageur Pharmaceuticals, atai... - Proactive Investors

May 13, 2025

May 13, 2025

Candel Therapeutics (CADL) Reports Q1 Earnings and Cash Reserves - GuruFocus

May 13, 2025

May 13, 2025

Market movers: Coinbase, Hertz, Candel Therapeutics, JD Sports... - Proactive Investors

May 13, 2025

May 13, 2025

Cardell Flat on Q1 - Baystreet.ca

May 13, 2025

May 13, 2025

Candel Therapeutics posts Q1 profit, eyes 2026 BLA submission for prostate cancer drug - Proactive financial news

May 13, 2025

May 13, 2025

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN

May 13, 2025

May 13, 2025

Candel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025

May 13, 2025

Wells Fargo & Company MN Increases Stake in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World

May 13, 2025

May 12, 2025

Barclays PLC Purchases 5,629 Shares of Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World

May 12, 2025

May 11, 2025

Candel Therapeutics (CADL) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025

May 07, 2025

Candel Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire

May 07, 2025

May 07, 2025

Candel Therapeutics (NASDAQ:CADL) vs. Calidi Biotherapeutics (NYSE:CLDI) Critical Review - Defense World

May 07, 2025

May 06, 2025

Candel Therapeutics to present at upcoming healthcare conferences - Proactive financial news

May 06, 2025

May 06, 2025

Candel Therapeutics to Present at Upcoming Investor Conferences in May and June 2025 - Nasdaq

May 06, 2025

May 01, 2025

Candel Therapeutics Inc [CADL] stock for 396,995 USD was sold by Nichols William Garrett - knoxdaily.com

May 01, 2025

May 01, 2025

Is Candel Therapeutics Inc (CADL) worth investing in despite its overvalued state? - uspostnews.com

May 01, 2025

May 01, 2025

LPL Financial LLC Makes New Investment in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World

May 01, 2025

Apr 29, 2025

Financial Metrics Check: Candel Therapeutics Inc (CADL)’s Ratios for Trailing Twelve Months - DWinneX

Apr 29, 2025

Apr 28, 2025

Geode Capital Management LLC Grows Stock Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World

Apr 28, 2025

Apr 25, 2025

S3e01 Life Changing Innovation with Paul Peter Tak, CEO of Candel Therapeutics - iHeart

Apr 25, 2025

Apr 25, 2025

A new trading data show Candel Therapeutics Inc (CADL) is showing positive returns. - Sete News

Apr 25, 2025

Apr 23, 2025

Candel Therapeutics to Present Prostate Cancer Trial Data By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

Candel Therapeutics to Present Prostate Cancer Trial Data - Investing.com

Apr 23, 2025

Apr 23, 2025

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025 - The Manila Times

Apr 23, 2025

Apr 23, 2025

Candel Therapeutics Announces Oral Presentation of CAN-2409 Data at 2025 ASCO Annual Meeting - Nasdaq

Apr 23, 2025

Apr 23, 2025

Candel Therapeutics Announces Oral Presentation of Positive - GlobeNewswire

Apr 23, 2025

Apr 23, 2025

Major Phase 3 Trial Results: Breakthrough Prostate Cancer Treatment Data to be Revealed at ASCO 2025 - Stock Titan

Apr 23, 2025

Apr 23, 2025

Candel Therapeutics to present Phase 3 prostate cancer data at 2025 ASCO Annual Meeting - Proactive Investors

Apr 23, 2025

Apr 23, 2025

Technical analysis of Candel Therapeutics Inc (CADL) stock chart patterns - uspostnews.com

Apr 23, 2025

Apr 23, 2025

How To Trade (CADL) - news.stocktradersdaily.com

Apr 23, 2025

Apr 13, 2025

Candel Therapeutics (NASDAQ:CADL) Earns “Buy” Rating from HC Wainwright - Defense World

Apr 13, 2025

Apr 12, 2025

Critical Review: Candel Therapeutics (NASDAQ:CADL) & ProKidney (NASDAQ:PROK) - Defense World

Apr 12, 2025

Apr 11, 2025

H.C. Wainwright maintains Buy on Candel Therapeutics stock By Investing.com - Investing.com Canada

Apr 11, 2025

Apr 11, 2025

H.C. Wainwright maintains Buy on Candel Therapeutics stock - Investing.com Australia

Apr 11, 2025